05 September 2022

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

05 September 2022 | n=24

  1. Wong NS, Wong BCK, Chan JMC, Wong KH, et al.
    Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors' reply.
    AIDS 2022;36:1747-1748.

  2. Mungmunpuntipantip R, Wiwanitkit V.
    Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV.
    AIDS 2022;36:1746-1747.

  3. Jonas KJ, Parczewski M, van de Vijver D.
    The war refugees from Ukraine: an HIV epidemic is fleeing as well.
    AIDS 2022;36:1745-1746.

  4. Langlie J, Mittal R, Bencie NB, Sharma U, et al.
    Unraveling the mechanisms of HIV-induced hearing loss.
    AIDS 2022;36:1737-1740.

  5. Martinez E.
    The right balance between weight gain and insulin sensitivity with integrase inhibitors.
    AIDS 2022;36:1735-1736.

  6. Milic J, Guaraldi G.
    Hormone therapy in postmenopausal women living with HIV: a view towards prevention of multiple metabolic conditions and improvement of quality of life.
    AIDS 2022;36:1731-1733.

  7. Lubega J, Grimes A, Airewele G, Bulsara S, et al.
    Risk factors and prognostic significance of anemia in children with hiv infection on anti-retroviral therap.
    AIDS 2022.

  8. Gedela K, Da Silva Fontoura D, Salam A, Gorman G, et al.
    Infectious proctitis due to human monkeypox.
    Clin Infect Dis 2022.

  9. Chew KW, Wu K, Tassiopoulos K, Palella FJ, et al.
    Liver inflammation is common and linked to metabolic derangements in persons with treated HIV.
    Clin Infect Dis 2022.

  10. Rocco JM, Laidlaw E, Galindo F, Anderson M, et al.
    Severe mycobacterial IRIS in advanced HIV has features of hemophagocytic lymphohistiocytosis and requires prolonged immune suppression.
    Clin Infect Dis 2022.

  11. Pettit AC, Phillips PP, Kurbatova E, Vernon A, et al.
    Rifapentine with and without moxifloxacin for pulmonary tuberculosis in people with HIV (S31/A5349).
    Clin Infect Dis 2022.

  12. Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, et al.
    Update of Perinatal HIV-1 Transmission in France: zero transmission for 5482 mothers on continuous ART from conception and with undetectable viral load at delivery.
    Clin Infect Dis 2022.

  13. Burry J, Casas CP, Ford N.
    Access to medicines for treating people with cryptococcal meningitis.
    Clin Infect Dis 2022.

  14. Nelson BS, Tierney C, Persaud D, Jao J, et al.
    Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life.
    Clin Infect Dis 2022.

  15. Fernandez OE, Gudipati S, Ko D, Boucher A, et al.
    Papillomatous Anogenital Lesions in a Patient With Human Immunodeficiency Virus.
    Clin Infect Dis 2022;75:172-175.

  16. Skeggs J, MacPhail A, Korman T, Woolley I, et al.
    Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data.
    Clin Infect Dis 2022.

  17. Fisher BT, Boge CLK, Xiao R, Shuster S, et al.
    Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.
    Clin Infect Dis 2022;75:248-259.

  18. Coburn SB, Lang R, Zhang J, Palella FJ, et al.
    Statins utilization in adults with HIV: The treatment gap and predictors of statin initiation.
    J Acquir Immune Defic Syndr 2022.

  19. Coutinho CM, Warshaw MG, Duarte G, Stek A, et al.
    Effects of initiating raltegravir-based versus efavirenz-based antiretroviral regimens during pregnancy on weight changes and perinatal outcomes: NICHD P1081.
    J Acquir Immune Defic Syndr 2022.

  20. Muyindike WR, Fatch R, Cheng DM, Emenyonu NI, et al.
    Unhealthy Alcohol Use is Associated with sub-Optimal Adherence to Isoniazid Preventive Therapy in Persons with HIV in southwestern Uganda.
    J Acquir Immune Defic Syndr 2022.

  21. Gayedyu-Dennis D, Fallah MP, Drew C, Badio M, et al.
    Identifying pauci-/asymptomatic and unrecognized Ebola virus disease among close contacts based on exposure risk assessments and screening algorithms.
    J Infect Dis 2022.

  22. Geng Y, Wang Y.
    Stability and transmissibility of SARS-CoV-2 in the environment.
    J Med Virol 2022.

  23. Conradie F, Bagdasaryan TR, Borisov S, Howell P, et al.
    Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
    N Engl J Med 2022;387:810-823.

  24. Patel K, Huo Y, Jao J, Powis KM, et al.
    Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.
    N Engl J Med 2022;387:799-809.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

15 April 2024

08 April 2024

01 April 2024

25 March 2024

18 March 2024


05 September 2022

Multidisciplinary Journal Club

  1. Steinman L, Fox E, Hartung HP, Alvarez E, et al.
    Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
    N Engl J Med. 2022;387:704-714.

  2. Chou R, Cantor A, Dana T, Wagner J, et al.
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;328:754-771.

  3. Schmitz T, Doret-Dion M, Sentilhes L, Parant O, et al.
    Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial.
    Lancet. 2022;400:592-604.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Privacy Policy